August 2, 2022
Alnylam Named #1 Best Workplace for Innovators by Fast Company
Alnylam has been named the #1 Best Workplace for Innovators by Fast Company for 2022.
Read More ›
July 13, 2022
Partnering with Nucleate to Support Young Biotech Entrepreneurs
Alnylam is partnering with Nucleate to remove barriers for young biotech entrepreneurs...
Read More ›
June 20, 2022
Challenging Ourselves to Help Refugees: Supporting Refugees to Become Work-Ready
Alnylam has announced a three-year corporate partnership with Refugee Action, a United Kingdom (UK)-based charity dedicated to helping refugees...
Read More ›
May 13, 2022
Hypertension: Charting A New Course to Address a Public Health Challenge
Hypertension (high blood pressure) has seen limited medical innovation in recent history and remains a serious public health issue...
Read More ›
May 9, 2022
Building a Collaborative Framework for Facilitating Patient Access to Innovative Therapies
Alnylam worked with leading European economists and other healthcare experts to develop what we call the Value-Based Negotiation Framework (VBNF) to help...
Read More ›
April 15, 2022
2021 Annual Report: CEO Yvonne Greenstreet Reflects on an Important Year in the RNAi Revol ...
In conjunction with the publishing of Alnylam's 2021 Annual Report, Alnylam's CEO Yvonne Greenstreet reflects on the year that was...
Read More ›
April 2, 2022
The Making of Two of Me: Living with Porphyria
Cynthia Lowen, Emmy-nominated filmmaker, talks about the making of Two of Me: Living with Porphyria.
Read More ›
March 16, 2022
Alnylam Publishes 2021 Corporate Responsibility Report
We're committed to taking bold actions that improve the health of humanity. Our 2021 Corporate Responsibility Report provides details on our progress...
Read More ›
February 28, 2022
Supporting Health Equity for All Through Leadership, Action and Partnership
"Health equity" means that everyone has a fair and just opportunity to live the healthiest life possible, regardless of who they are, where they live or how...
Read More ›
February 4, 2022
Alnylam Receives Prestigious Massachusetts Economic Impact Award
We are pleased and honored to have been named a Gold Team Massachusetts Economic Impact Award winner for 2022 by MassEcon.
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site